Dig Howitt

Dig Howitt serves as CEO and President of Cochlear Limited, the world's leading manufacturer of implantable hearing solutions headquartered in Sydney, Australia. Cochlear commands approximately 60% of the global cochlear implant market — a dominant position it has held for decades through continuous investment in R&D, clinical evidence generation, and surgeon training. The company has helped over 700,000 people with severe-to-profound hearing loss experience hearing for the first time or regain lost hearing. Cochlear's addressable market is vastly underpenetrated: an estimated 5% of the 460+ million people globally who could benefit from cochlear implants have actually received them. This penetration gap represents an enormous long-term growth opportunity as awareness increases, surgical access improves in developing countries, and insurance coverage expands. Cochlear has also expanded into bone conduction and acoustic implants for different types of hearing loss. Howitt's strategic priorities include growing cochlear implant adoption globally (particularly in emerging markets with growing healthcare infrastructure), expanding the addressable market through clinical evidence for milder hearing loss, developing next-generation processors and software that improve hearing outcomes, and building the services and digital health platform that creates recurring revenue from the growing installed base. His decisions on R&D investment, market development, regulatory strategy, and geographic expansion are the primary drivers of this premium-valued medtech stock.